Welcome to our dedicated page for Centrus Energy SEC filings (Ticker: LEU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Centrus Energy Corp. filings document operating results and material events for a nuclear fuel supplier with LEU and Technical Solutions activities. Recent 8-K reports furnish quarterly and annual results, press releases on centrifuge manufacturing, enrichment operations, and expansion initiatives tied to Low-Enriched Uranium and High-Assay, Low-Enriched Uranium.
Proxy and governance filings describe director-election mechanics, executive compensation, shareholder voting standards, universal proxy procedures, forum-selection provisions, and other bylaw changes. The filing record also covers material agreements, capital-structure topics, governance matters, and disclosures related to the company’s nuclear fuel services and manufacturing programs.
Centrus Energy has secured a significant contract amendment with the U.S. Department of Energy regarding its HALEU (High-Assay, Low-Enriched Uranium) Demonstration Cascade project. The original contract's first three-year option period has been split into two parts:
Key Financial Terms:
- Option 1a (1-year): Target cost of $99.3 million with fee of $8.7 million
- Option 1b (2-years): Target cost of $163.5 million with fee of $15.2 million
- DOE has exercised Option 1a, valued at approximately $110 million, extending performance to June 30, 2026
The amendment acknowledges that Option 1b's estimated cost is insufficient due to cost increases since the original contract award. ACO must submit a revised cost proposal before DOE considers Option 1b. All HALEU produced under this contract remains Department property.